The latest dataset was made available in EQUIPP® as of June 9, 2023. This dataset now includes 6-month performance information based off of prescription drug claims from November 1, 2023 through April 30, 2023.
YTD Date Range: January 1, 2023 - April 30, 2023
Things to Know:
Webinar Recordings - Please visit our New Resource Materials Section for our most recently recorded webinars.
Influenza Performance Update:
The Influenza Vaccination measures is now available in EQUIPP® and will be tracked through the 2022-2023 flu season, with a final measurement date ending March 31, 2023. Note: This reporting period for the 2022-2023 Flu season has concluded.
Latest Feature: We’ve heard your feedback for a list of all patients and now the feature is here! The All Patients View is a comprehensive view of all patients attributed to your pharmacy in the EQUIPP platform. For navigation tips, please visit our EQUIPP Resources.
NEW! Updated EQUIPP Videos
PQS has updated EQUIPP educational videos to match our current platform. Our first three videos can be accessed in this YouTube playlist.
Trade Show Schedule
Do you have questions about EQUIPP? Mark your calendars! PQS will be attending McKesson IdeaShare on June 22 - 25, 2023 in Las Vegas, the Cardinal Trade Show July 19 - 22, 2023 in Boston, MA, and AmerisourceBergen's ThoughtSpot on August 2 - 5, 2023 in Las Vegas.
MEASURE YEAR 2023 PHARMACY QUALITY ALLIANCE:
All Pharmacy Quality Alliance measures in EQUIPP have been updated to match the MY2023 specifications as updated by the Pharmacy Quality Alliance.
Here are some notable changes:
- Tirzepatide (Mounjaro) has been added to Diabetes PDC and to Statin Use in Persons with Diabetes (SUPD)
- Oral cladribine has been revised to be a medication exclusion for Multiple Sclerosis PDC
- The combination of atorvastatin and ezetimibe has been added to Cholesterol PDC and to SUPD